Patents by Inventor Peter Wisniecki

Peter Wisniecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE
    Publication number: 20100003331
    Abstract: A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: September 3, 2009
    Publication date: January 7, 2010
    Applicant: Pfizer Inc.
    Inventors: Imran Ahmed, Leah Elizabeth Appel, Walter Christian Babcock, Dwayne Thomas Friesen, Scott Herbig, David Keith Lyon, Sheri L. Shamblin, Ravi Mysore Shanker, Daniel Tod Smithey, Steven C. Sutton, Avinash Govind Thombre, Kenneth C. Waterman, Jaymin C. Shah, Parag Suresh Shah, Peter Wisniecki, Dawn Renee Wagner
  • INJECTABLE DEPOT FORMULATIONS AND METHODS FOR PROVIDING SUSTAINED RELEASE OF NANOPARTICLE COMPOSITIONS
    Publication number: 20080305161
    Abstract: Pharmaceutical formulations comprising: a compound selected from the group consisting of ziprasidone, having a maximum average particle size; a carrier; and preferably at least two surface stabilizers are disclosed. The present invention also comprises methods of treating psychosis with such a formulation and processes for making such a formulation.
    Type: Application
    Filed: March 5, 2008
    Publication date: December 11, 2008
    Inventors: Jaymin C. Shah, Parag Suresh Shah, Peter Wisniecki, Dawn Renee Wagner
  • Parenteral and oral formulations of benzimidazoles
    Publication number: 20080293796
    Abstract: Provided herein are drug delivery systems comprising nanosuspension formulations suitable for parenteral delivery to a subject. The nanosuspension formulations may comprise a benzimidazole derivative, e.g., mebendazole, and surface stabilizers, such as block copolymer(s), e.g., Pluronic F108, and surfactant(s), e.g., Tween 80, and, optionally, water. Provided are methods for defining nanosuspensions of a benzimidazole derivative as having maximum therapeutic efficacy for a treatment regimen by adjusting and/or selecting particles size(s) based on pharmacokinetic parameters of the derivative in the tissue.
    Type: Application
    Filed: July 24, 2008
    Publication date: November 27, 2008
    Inventors: Diana Shu-Lian Chow, Pranav Gupta, Yulan Qi, Jaymin Shah, Peter Wisniecki
  • Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle Compositions
    Publication number: 20080193542
    Abstract: Pharmaceutical formulations comprising: a compound selected from the group consisting of ziprasidone, having a maximum average particle size; a carrier; and preferably at least two surface stabilizers are disclosed. The present invention also comprises methods of treating psychosis with such a formulation and processes for making such a formulation.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 14, 2008
    Inventors: Jaymin C. Shah, Parag Suresh Shah, Peter Wisniecki, Dawn Renee Wagner
  • Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
    Publication number: 20080166411
    Abstract: Pharmaceutical formulations comprising: a compound of low water solubility, having a maximum average particle size; a carrier; and at least two surface stabilizers are disclosed. The present invention also comprises methods of treating various conditions with such a formulation and processes for making such a formulation.
    Type: Application
    Filed: April 10, 2006
    Publication date: July 10, 2008
    Inventors: Jaymin C. Shah, Parah Suresh Shah, Dawn Renee Wagner, Peter Wisniecki